Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
Conditions
Advanced Biliary Tract Carcinoma · Advanced Head and Neck Squamous Cell Carcinoma · Advanced Hepatocellular Carcinoma · Advanced Lung Non-Small Cell Carcinoma · Advanced Malignant Solid Neoplasm · Advanced Melanoma · Advanced Renal Cell Carcinoma · Metastatic Biliary Tract Carcinoma · Metastatic Head and Neck Squamous Cell Carcinoma · Metastatic Hepatocellular Carcinoma · Metastatic Lung Non-Small Cell Carcinoma · Metastatic Malignant Solid Neoplasm · Metastatic Melanoma · Metastatic Renal Cell Carcinoma · Recurrent Head and Neck Squamous Cell Carcinoma · Stage III Hepatocellular Carcinoma AJCC v8 · Stage III Lung Cancer AJCC v8 · Stage III Renal Cell Cancer AJCC v8 · Stage IV Hepatocellular Carcinoma AJCC v8 · Stage IV Lung Cancer AJCC v8 · Stage IV Renal Cell Cancer AJCC v8
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
OHSU Knight Cancer Institute, Portland, Oregon, United States
Contact: Principal Investigator (Rajat Thawani)
Study leads
Rajat Thawani
Principal Investigator
OHSU Knight Cancer Institute